- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2024
- 265 Pages
Global
From €4235EUR$4,455USD£3,558GBP
€4706EUR$4,950USD£3,953GBP
- Report
- June 2022
- 283 Pages
United States
From €2495EUR$2,625USD£2,096GBP
€4991EUR$5,250USD£4,193GBP
- Report
- June 2023
- 89 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- October 2022
- 225 Pages
Global
From €3394EUR$3,570USD£2,851GBP
The Tumor Testing market is a subset of the Laboratory Testing market, which involves the analysis of biological samples to detect and diagnose diseases. Tumor Testing specifically involves the analysis of tissue samples to detect and diagnose cancer. This type of testing is used to identify the type of cancer, its stage, and its aggressiveness. It is also used to monitor the effectiveness of treatments and to detect recurrence. Tumor Testing is typically performed in a laboratory setting, and the results are used to inform treatment decisions.
The Tumor Testing market is highly competitive, with a range of companies offering products and services. Examples include Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Becton Dickinson, and Quest Diagnostics. Show Less Read more